Massive pulmonary hemorrhage in a patient treated with a platelet glycoprotein IIb/IIIa inhibitor

International Journal of Cardiology

Volumn 62, Issue 3, 1997, Pages 269-271

  Sitges, Marta ^a   Villa, Fèlix Pérez ^a  

^a Inst de Malalties Cardiovasculars   (Spain)

Author keywords

Bleeding complications; Platelet glycoprotein IIb IIIa inhibitors; PTCA; Pulmonary hemorrhage

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADRENALIN; DOBUTAMINE; DOPAMINE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PROTAMINE;

AGED; AORTA BALLOON; ARTICLE; CASE REPORT; ERYTHROCYTE CONCENTRATE; FATALITY; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG HEMORRHAGE; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ELECTROCARDIOGRAPHY; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LUNG DISEASES; MALE; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; THROMBOSIS; TREATMENT OUTCOME;

EID: 0031578884     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00228-3     Document Type: Article

References (5)

1. The EPIC Investigators. Use of monoclonal antibody against the platelet glycoprotein IIb/IIIa in high risk coronary angioplasty. N Engl J Med 1994;330:956-61.
2. Aguirre FV, Topol EJ, Ferguson JJ, Anderson K, Blankenship JC, Heuser RRet al. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation. 91(12):1995;2882-2890.
3. Cuellar Obispo E, Torrado Gonzalez E, Alvarez Bueno M, Ferriz Martin JA, Vera Almazan A, Rodriguez Garcia JJ A diffuse pulmonary hemorrhage following thrombolytic therapy in acute myocardial infarction. Rev Esp Cardiol. 45(6):1992;421-424.
4. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.
5. Tcheng JE Glycoprotein IIb/IIIa inhibitors: putting the EPIC, IMPACT II; RESTORE; and EPILOG trials into perspective. Am J Cardiol. 78(3A):1996;35-40.